Please enable Javascript
organ failure
Advertisement
DARE-19: Dapagliflozin Does Not Reduce Organ Failure in COVID-19 Patients
DocWire News Editors
ACC 2021 Conference
|
April 19, 2023
In high-risk patients hospitalized with COVID-19, the administration of the SGLT2 inhibitor dapagliflozin was not ...
Read More
Advertisement
Advertisement